KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to $376.3 million.

  • Exelixis' Cash & Equivalents rose 45.66% to $376.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $376.3 million, marking a year-over-year increase of 45.66%. This contributed to the annual value of $217.4 million for FY2025, which is 17.35% down from last year.
  • Exelixis' Cash & Equivalents amounted to $376.3 million in Q4 2025, which was up 128.85% from $164.4 million recorded in Q3 2025.
  • Exelixis' 5-year Cash & Equivalents high stood at $723.3 million for Q2 2022, and its period low was $164.4 million during Q3 2025.
  • In the last 3 years, Exelixis' Cash & Equivalents had a median value of $259.6 million in 2024 and averaged $302.1 million.
  • In the last 5 years, Exelixis' Cash & Equivalents soared by 102.74% in 2021 and then tumbled by 57.27% in 2024.
  • Exelixis' Cash & Equivalents (Quarterly) stood at $647.2 million in 2021, then declined by 22.56% to $501.2 million in 2022, then tumbled by 47.53% to $263.0 million in 2023, then slumped by 34.90% to $258.3 million in 2024, then soared by 45.66% to $376.3 million in 2025.
  • Its last three reported values are $376.3 million in Q4 2025, $164.4 million for Q3 2025, and $183.8 million during Q2 2025.